Skip to main content
logo
Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.300
-0.010 (-0.76%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Fate Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
1511131883699825,601
Market Cap Growth
41.12%-39.70%-49.04%-62.43%-82.47%-29.78%
Enterprise Value
25.33-17.01-13.23151.05649.195,094
Last Close Price
1.300.981.653.7410.0958.51
PE Ratio
--0.85-1.01-2.28-3.47-26.12
PS Ratio
22.7417.0613.795.8110.19100.29
PB Ratio
0.720.550.591.002.038.25
P/TBV Ratio
0.750.560.591.002.028.17
P/FCF Ratio
--1.01-1.52-2.66-3.46-26.22
P/OCF Ratio
--1.07-1.53-2.79-3.96-34.39
EV/Sales Ratio
3.81-2.56-0.972.386.7491.22
EV/EBITDA Ratio
-0.130.07-0.88-2.20-24.13
EV/EBIT Ratio
-0.120.06-0.79-2.11-23.48
EV/FCF Ratio
-0.150.11-1.09-2.29-23.85
Debt / Equity Ratio
0.350.350.240.260.210.16
Debt / EBITDA Ratio
-0.58-0.58-0.45-0.60-0.37-0.54
Debt / FCF Ratio
-0.69-0.69-0.69-0.75-0.38-0.54
Net Debt / Equity Ratio
-0.61-0.61-0.61-0.57-0.67-0.74
Net Debt / EBITDA Ratio
0.930.931.011.231.112.37
Net Debt / FCF Ratio
1.121.121.571.531.152.35
Asset Turnover
0.020.020.030.100.120.07
Quick Ratio
5.675.677.348.114.167.68
Current Ratio
5.795.797.588.484.407.79
Return on Equity (ROE)
-51.84%-51.84%-54.21%-37.76%-48.46%-39.90%
Return on Assets (ROA)
-38.89%-38.89%-44.41%-31.44%-37.91%-28.11%
Return on Invested Capital (ROIC)
-132.17%-132.17%-145.16%-104.12%-133.60%-116.60%
Return on Capital Employed (ROCE)
-43.12%-43.12%-48.38%-35.99%-43.08%-31.52%
Earnings Yield
-90.19%-117.04%-99.39%-43.85%-28.84%-3.83%
FCF Yield
-74.13%-98.84%-65.75%-37.52%-28.91%-3.81%
Buyback Yield / Dilution
-4.49%-4.49%-15.86%-1.34%-2.19%-15.01%
Total Shareholder Return
-4.49%-4.49%-15.86%-1.34%-2.19%-15.01%
Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q